Sign inGet started

Rohlen Douglas

Insider CIK 1306344 · ENTL Director · EIDX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
EIDX Eidos Therapeutics, Inc. D To issuer deriv2021-01-262021-01-2821,447— $00SEC↗
EIDX Eidos Therapeutics, Inc. D To issuer deriv2021-01-262021-01-284,526— $00SEC↗
EIDX Eidos Therapeutics, Inc. A Award deriv2020-08-062020-08-104,526— $04,526SEC↗
EIDX Eidos Therapeutics, Inc. A Award deriv2020-08-062020-08-1021,447— $021,447SEC↗
ENTL ENTELLUS MEDICAL INC D To issuer deriv2018-02-282018-03-017,500$6.33 $47.5K0SEC↗
ENTL ENTELLUS MEDICAL INC D To issuer2018-02-282018-03-014,684$24.00 $112.4K0SEC↗
ENTL ENTELLUS MEDICAL INC D To issuer2018-02-282018-03-016,834$24.00 $164.0K0SEC↗
ENTL ENTELLUS MEDICAL INC D To issuer2018-02-282018-03-0120,299$24.00 $487.2K0SEC↗
ENTL ENTELLUS MEDICAL INC D To issuer2018-02-282018-03-019,217$24.00 $221.2K0SEC↗
ENTL ENTELLUS MEDICAL INC A Award deriv2017-07-142017-07-187,500— $07,500SEC↗
ENTL ENTELLUS MEDICAL INC A Award2017-07-142017-07-183,750— $09,217SEC↗